Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Corona. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Corona location
Access ulcerative colitis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
Check if you qualify for this ulcerative colitis clinical trial in Corona, CA
No-Cost Study Care
Local to Corona
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how safe and effective Upadacitinib is in treating pediatric participants with UC. Adverse events and change in disease activity will be assessed. Upadacitinib (RINVOQ) is a drug approved in adults for moderate- to severely active UC and is being developed for moderate- to severely active UC in pediatric participa
Sponsor: AbbVie
Yes, this clinical trial (NCT05782907) has an active research site in Corona, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for ulcerative colitis treatment options in Corona, CA, this clinical trial (NCT05782907) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Corona research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all ulcerative colitis clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Corona — not just this study.
Browse Rheumatoid Arthritis Trials in Corona →